CD59 Antibody (YA4692)

(Synonyms: CD59; MIC11; MIN1; MIN2; MIN3; MSK21; CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor; HRF-20; HRF20; MAC-inhibitory protein; MAC-IP; MEM43 antigen; Membrane attack complex inhibition factor; MACIF; Membrane inhibitor of reactive lysis; MIRL; Protectin; CD59; CD59 nanobody; )

CD59 Antibody (YA4692) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD59.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Application:

    ELISA

  • Reactivity :

    Human

  • Formulation:

    Supplied in Phosphate-buffered solution.

  • Conjugation:
    Non-conjugated

Applications

Application
ELISA Info
ELISA: Enzyme Linked Immunosorbent Assay
Dilution Ratio 1:5000-100000

Product Details

Description

CD59 Antibody (YA4692) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD59.

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human
Immunogen

Purified recombinant Human CD59

Purification

affinity purified.

Conjugation

Non-conjugated

Modification

Unmodified

Product Properties

  • Appearance

    Liquid

  • Formulation

    Supplied in Phosphate-buffered solution.

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    CD59 is a Potent inhibitor of the complement membrane attack complex (MAC) action, which protects human cells from damage during complement activation. Acts by binding to the beta-haipins of C8 (C8A and C8B) components of the assembling MAC, forming an intermolecular beta-sheet that prevents incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore; The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit complement membrane attack complex (MAC) assembly on cell membranes[1][2][3][4][5][6][7].

  • Subcellular Localization

    Cell membrane; Lipid-anchor, GPI-anchor; Secreted

  • Isoforms & Post-Translational Modification

    P13987 has 2 isomers: P13987-1: 14177 Da (predicted); P13987-2: 14529 Da (predicted).
    N- and O-glycosylated. The N-glycosylation mainly consists of a family of biantennary complex-type structures with and without lactosamine extensions and outer arm fucose residues. Also significant amounts of triantennary complexes (22%). Variable sialylation also present in the Asn-43 oligosaccharide. The predominant O-glycans are mono-sialylated forms of the disaccharide, Gal-beta-1,3GalNAc, and their sites of attachment are probably on Thr-76 and Thr-77. The GPI-anchor of soluble urinary CD59 has no inositol-associated phospholipid, but is composed of seven different GPI-anchor variants of one or more monosaccharide units. Major variants contain sialic acid, mannose and glucosamine. Sialic acid linked to an N-acetylhexosamine-galactose arm is present in two variants;Glycated (PubMed:10805801). Glycation is found in diabetic subjects, but only at minimal levels in nondiabetic subjects. Glycated CD59 lacks MAC-inhibitory function and confers to vascular complications of diabetes (PubMed:10805801)

  • Subunit

    Interacts with T-cell surface antigen CD2

  • SwissProt ID

    P13987

  • Gene ID
    966 [NCBI]
  • Synonyms

    CD59; MIC11; MIN1; MIN2; MIN3; MSK21; CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor; HRF-20; HRF20; MAC-inhibitory protein; MAC-IP; MEM43 antigen; Membrane attack complex inhibition factor; MACIF; Membrane inhibitor of reactive lysis; MIRL; Protectin; CD59; CD59 nanobody;

CD59 Antibody (YA4692) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00